ISAL 2023 | Investigating the incidence and outcomes of CNS relapse in patients with ALL
Robin Foà
• 23 Mar 2023
In this video, Robin Foà, MD, Sapienza University of Rome, Rome, Italy, discusses the rate of CNS relapse being observed in patients with acute lymphoblastic leukemia (ALL). Prof. Foà highlights ongoing research which is evaluating whether certain genes may predispose patients to CNS relapse, which may then allow clinicians to identify patients in need of more effective CNS prophylaxis. This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
